Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Health Canada Extension on Nitrosamine Risk Assessments

Apr 3, 2020

Earlier this year, information about new regulations and requirements put in place by Health Canada for product’s containing nitrosamine impurities was released. These regulations are applicable to prescription and non-prescription pharmaceuticals containing...

Updates to FDA Regulations for COVID-19 Essential Products

Mar 27, 2020

The U.S. FDA has released new regulations for essential products that will aid in limiting the spread of coronavirus, such as sanitizers. These new regulations have been placed into effect immediately and are being modified and reintroduced in order to minimize the...

Health Canada’s Actions to Minimize the Spread of COVID-19

Mar 27, 2020

During the current COVID-19 pandemic, the government’s regulatory bodies have decided to take supportive steps to discourage the spread of the virus. These steps include temporarily modifying the regulatory process for disinfectant and sanitization products to allow...

Less Testing for Imported Low-Risk OTC Drugs – Temporarily

Mar 27, 2020

Health Canada and the Public Health Agency of Canada continue to put their best efforts forward with assisting the supply and demand of products for Canadians amidst the battle against the COVID-19 pandemic. Health Canada has expanded their previously released DEL...

COVID-19 Impact on Cosmetic and Medical Device Industry

Mar 17, 2020

COVID-19, otherwise known as the coronavirus, has been of increasing public concern in recent months and has now infected over 100 000 people worldwide. The rise of cases has had a clear impact on industries and the economy, and the cosmetic and medical device...

49th Amendment to the International Fragrance Association Code of Practice

Mar 12, 2020

The International Fragrance Association (IFRA) have recently released the 49th amendment to their Code of Practice, the largest update in years. IFRA has been promoting the safety of fragrances in products since 1973. The self-regulating body has been promoting safety...

Patents: Misconceptions and Watch-Outs”.

Feb 20, 2020

An entrepreneur recently told me she had discovered a new use for an old molecule. She was not sure about moving ahead with it because patent protection was not solid. I said “so what”, just to be provocative. Then I told her that having patent protection was not the...

The Need for Pharmaceutical and Medical Device Advancements in the Race Against Coronavirus

Feb 19, 2020

The topic on everyone’s mind lately has been a new virus discovered in Wuhan City, China known as novel coronavirus or 2019-nCoV. The World Health Organization (WHO) was made aware of an abnormal increase in cases of pneumonia in the Chinese city on December 31, 2019....

New Hair and Skin Models Indicate an Animal Friendly Future

Feb 18, 2020

The new year has just begun, and it is already friendlier than last year- at least more animal friendly that is! It is clear in today’s society that cruelty-free products are very important to cosmetic consumers and will likely continue to increase in importance....

How to Handle Complaints Made About Your Innovation

Feb 15, 2020

A lot of people have been contacting me about complaints made about their innovations. Now to be clear, I’m not referring to things like Google reviews although these may or may not be relevant. I am thinking of complaints made directly to the company about the...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us